Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-009968
Filing Date
2025-05-13
Accepted
2025-05-13 16:30:37
Documents
81
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-K form10-k.htm   iXBRL 10-K 1232313
2 EX-31.1 ex31-1.htm EX-31.1 11772
3 EX-31.2 ex31-2.htm EX-31.2 11819
4 EX-32.1 ex32-1.htm EX-32.1 6326
5 EX-32.2 ex32-2.htm EX-32.2 6424
  Complete submission text file 0001641172-25-009968.txt   6225286

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rgbp-20240930.xsd EX-101.SCH 55223
7 XBRL CALCULATION FILE rgbp-20240930_cal.xml EX-101.CAL 73967
8 XBRL DEFINITION FILE rgbp-20240930_def.xml EX-101.DEF 221828
9 XBRL LABEL FILE rgbp-20240930_lab.xml EX-101.LAB 341100
10 XBRL PRESENTATION FILE rgbp-20240930_pre.xml EX-101.PRE 309751
84 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 895016
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

EIN.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-191725 | Film No.: 25940649
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)